Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Ilkka Oyj Stock Exchange Release 27 March 2026, at 07:00 p.m. EETIlkka Oyj: Acquisition of own shares on 27 March 2026 Date27 March 2026 Exchange transactionBuy Share...
-
Ilkka Oyj Pörssitiedote 27.3.2026, klo 19:00 Ilkka Oyj:n omien osakkeiden hankinta 27.3.2026 Päivämäärä27.3.2026 PörssikauppaOsto OsakelajiILKKA2 Osakemäärä (kpl)1...
-
Aðalfundur Kaldalóns hf. („Kaldalón“ eða „félagið“) sem haldinn var þann 26. mars 2026 samþykkti að heimila stjórn félagsins að kaupa hluti í félaginu þannig að félagið, að öðrum lagaskilyrðum...
-
The annual general meeting of Kaldalón hf. (“Kaldalón” or the “Company”), held on 26 March 2026, approved an authorisation for the Board of Directors to acquire shares in the Company so that, subject...
-
Sanoma Oyj, pörssitiedote, 27.03.2026 klo 18.30 SANOMA OYJ: OMIEN OSAKKEIDEN HANKINTA 27.03.2026 Nasdaq Helsinki Oy: Päivämäärä27.03.2026 PörssikauppaOsto OsakelajiSANOMA Osakemäärä, kpl23...
-
Sanoma Corporation, Stock exchange release, 27 March 2026 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 27 March 2026Nasdaq Helsinki Ltd: Date27 March 2026 Exchange transactionBuy Share...
-
NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Cambridge Acquisition Corp. (Nasdaq: CAQUU) (the “Company”) announced today that, commencing March 30, 2026, holders of the units sold in the Company’s...
-
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SOLANA BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced that it has entered into definitive agreements for the purchase and sale of an...
-
DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next...
-
Anaptys to spin-off biopharma operations into First Tracks Biotherapeutics, with a target distribution date of April 20, 2026Anaptys to manage the financial collaborations for Jemperli with GSK and...